Lamivudine And Zidovudine Tablet, Film Coated
Product Images NDC 43063-900

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lamivudine And Zidovudine (NDC 43063-900). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

43063900 Label (43063900)

Label for LAMIVUDINE and ZIDOVUDINE 150 mg / 300 mg film-coated tablets by PD-Rx Pharmaceuticals, Inc. The label shows the NDC 43063-900-06, contains 6 tablets, and includes lot number 12OC16 with expiration date 01/2022. It features dosage information blanks, warning to keep out of reach of children, and the manufacturer location as Oklahoma City, OK.*

FDA Label Image

Lamivudinestructure

Chemical structure of Lamivudine and Zidovudine, showing the molecular arrangement with nitrogen, oxygen, sulfur atoms, and hydroxyl groups typical of these antiviral agents.*

FDA Label Image

Zedovudinechemicalstructure

Chemical structure of lamivudine, showing its molecular composition with a cytosine base linked to a sugar moiety that includes an azido group. This is representative of one of the active ingredients in the product Lamivudine and Zidovudine tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.